Learn More
Medchemexpress LLC 1,3,4,5-tetrahydro-4-methyl-6-[1-methyl-3-(1-methyl-pyrazol-4-yl)-indazol-5-yl]-benzodiazepin-2-one | 1884712-47-3 | 100.0% | 386.45 g/mol | C22H22N6O | 1 ML

Supplier: Medchemexpress LLC HY10048210MM 1ML
CPI-637 is a selective, cell-active benzodiazepinone inhibitor of CBP and EP300 bromodomains with potent biochemical activity and demonstrated cellular effects. It inhibits CBP and EP300 with low-nanomolar IC50 values, shows reduced activity against BRD4 BD-1, and is supplied as a concentrated solution for research use.
- Selective CBP and EP300 bromodomain inhibition.
- Potent biochemical activity (low-nanomolar IC50 values).
- Cell-active with measurable EC50 in cellular assays.
- Supplied as a concentrated solution for convenient dosing in assays.
- Suitable for epigenetics and cancer biology research applications.
- Reported high chemical purity for reproducible results.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.